Kalahn Taylor-Clark

At-a-Glance

Current Vice President of Social Impact and Sustainability at Merck.
Leads enterprise strategy for purpose-driven impact and ESG priorities at Merck.
Oversees programs including the Mectizan Donation program and Merck for Mothers.
Served as Vice President and Head of Global Patient Outcomes and Innovation at Sanofi for seven years.
Led Patient Centeredness and Health Equity portfolios at the Brookings Institution.
Served as Senior Advisor and Assistant Professor at George Mason University’s Center for Health Policy, Research and Ethics.
Contributed to the development of Accountable Health Communities in Vermont, informing Medicaid’s Section 1115 waiver expansion.

Biography

Kalahn Taylor-Clark serves as the Vice President of Social Impact and Sustainability at Merck, where she leads the enterprise strategy to integrate purpose-driven impact with long-term business performance. In this role, she focuses on advancing a social investment strategy that strengthens community partnerships and embeds environmental, social, and governance (ESG) priorities across global operations.